Steroid Hormones Section, NIDDK/LERB, National Institutes of Health, Bethesda, MD, United States.
Mol Cell Endocrinol. 2012 May 15;355(1):121-34. doi: 10.1016/j.mce.2012.02.001. Epub 2012 Feb 11.
Increased specificity in steroid-regulated gene expression is a long-sought goal of endocrinologists. Considerable progress has resulted from the discovery of coactivators, corepressors, and comodulators that adjust the total activity (A(max)) of gene induction. Two less frequently quantitated, but equally potent, means of improving specificity are the concentration of agonist steroid required for half-maximal activity (EC(50)) and the residual or partial agonist activity displayed by most antisteroids (PAA). It is usually assumed that the modulatory activity of transcriptional cofactors coordinately regulates A(max), EC(50), and PAA. Here we examine the hypothesis that these three parameters can be independently modified by separate protein domains. The test system involves three differently sized fragments of each of three factors (glucocorticoid receptor [GR], coactivator TIF2, and comodulator STAMP), which are shown to form a ternary complex and similarly affect the induction properties of transfected and endogenous genes. Twenty-five different fragment combinations of the ternary complex are examined for their ability to modulate the A(max), EC(50), and PAA of a transiently transfected synthetic reporter gene. Different combinations selectively alter one, two, or all three parameters. These results clearly demonstrate that A(max), EC(50), and PAA can be independently regulated under some conditions by different pathways or molecular interactions. This new mechanistic insight suggests that selected activities of individual transcription factors are attractive targets for small molecules, which would have obvious clinical applications for increasing the specificity of steroids during endocrine therapies.
提高类固醇调节基因表达的特异性是内分泌学家长期追求的目标。由于发现了共激活因子、核心抑制因子和共调节剂,它们可以调节基因诱导的总活性(A(max)),因此取得了相当大的进展。两种较少被量化但同样有效的提高特异性的方法是达到半最大活性(EC(50))所需的激动剂类固醇浓度和大多数抗甾体(PAA)显示的剩余或部分激动剂活性。通常假设转录共因子的调节活性协同调节 A(max)、EC(50)和 PAA。在这里,我们检验了这样一个假设,即这三个参数可以通过独立的蛋白质结构域来独立修饰。测试系统涉及三个因子(糖皮质激素受体[GR]、共激活因子 TIF2 和共调节剂 STAMP)的每个因子的三个不同大小的片段,这些片段被证明可以形成三元复合物,并以类似的方式影响转染和内源性基因的诱导特性。对三元复合物的 25 种不同片段组合进行了研究,以研究它们调节瞬时转染合成报告基因的 A(max)、EC(50)和 PAA 的能力。不同的组合选择性地改变一个、两个或所有三个参数。这些结果清楚地表明,在某些条件下,A(max)、EC(50)和 PAA 可以通过不同的途径或分子相互作用独立调节。这种新的机制见解表明,单个转录因子的选定活性是小分子的有吸引力的靶标,这将在内分泌治疗期间提高类固醇的特异性方面具有明显的临床应用。